Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer

10.1158/1078-0432.CCR-21-4179

Saved in:

Bibliographic Details
Main Authors:	Lim, JSJ, Wong, ALA, Ow, SGW, Ngoi, NYL, Chan, GHJ, Ang, YLE, Chong, WQ, Lim, SE, Lim, YW, Lee, M, Choo, JRE, Tan, HL, Yong, WP, Soo, RA, Tan, DSP, Chee, CE, Sundar, R, Yadav, K, Jain, S, Wang, L, Tai, BC, Goh, BC, Lee, SC
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Article
Published:	American Association for Cancer Research (AACR) 2023
Subjects:	Antineoplastic Combined Chemotherapy Protocols Biomarkers, Tumor Breast Neoplasms Female Humans Letrozole Phenylurea Compounds Postmenopause Quinolines Receptor, ErbB-2 Receptors, Estrogen
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/236980
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-236980
record_format	dspace
spelling	sg-nus-scholar.10635-2369802024-04-18T02:15:28Z Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer Lim, JSJ Wong, ALA Ow, SGW Ngoi, NYL Chan, GHJ Ang, YLE Chong, WQ Lim, SE Lim, YW Lee, M Choo, JRE Tan, HL Yong, WP Soo, RA Tan, DSP Chee, CE Sundar, R Yadav, K Jain, S Wang, L Tai, BC Goh, BC Lee, SC CANCER SCIENCE INSTITUTE OF SINGAPORE MEDICINE SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH Antineoplastic Combined Chemotherapy Protocols Biomarkers, Tumor Breast Neoplasms Female Humans Letrozole Phenylurea Compounds Postmenopause Quinolines Receptor, ErbB-2 Receptors, Estrogen 10.1158/1078-0432.CCR-21-4179 Clinical Cancer Research 28 11 2248-2256 2023-02-08T07:16:55Z 2023-02-08T07:16:55Z 2022-06-01 2023-02-08T04:53:26Z Article Lim, JSJ, Wong, ALA, Ow, SGW, Ngoi, NYL, Chan, GHJ, Ang, YLE, Chong, WQ, Lim, SE, Lim, YW, Lee, M, Choo, JRE, Tan, HL, Yong, WP, Soo, RA, Tan, DSP, Chee, CE, Sundar, R, Yadav, K, Jain, S, Wang, L, Tai, BC, Goh, BC, Lee, SC (2022-06-01). Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer. Clinical Cancer Research 28 (11) : 2248-2256. ScholarBank@NUS Repository. https://doi.org/10.1158/1078-0432.CCR-21-4179 1078-0432 1557-3265 https://scholarbank.nus.edu.sg/handle/10635/236980 American Association for Cancer Research (AACR) Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Antineoplastic Combined Chemotherapy Protocols Biomarkers, Tumor Breast Neoplasms Female Humans Letrozole Phenylurea Compounds Postmenopause Quinolines Receptor, ErbB-2 Receptors, Estrogen
spellingShingle	Antineoplastic Combined Chemotherapy Protocols Biomarkers, Tumor Breast Neoplasms Female Humans Letrozole Phenylurea Compounds Postmenopause Quinolines Receptor, ErbB-2 Receptors, Estrogen Lim, JSJ Wong, ALA Ow, SGW Ngoi, NYL Chan, GHJ Ang, YLE Chong, WQ Lim, SE Lim, YW Lee, M Choo, JRE Tan, HL Yong, WP Soo, RA Tan, DSP Chee, CE Sundar, R Yadav, K Jain, S Wang, L Tai, BC Goh, BC Lee, SC Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer
description	10.1158/1078-0432.CCR-21-4179
author2	CANCER SCIENCE INSTITUTE OF SINGAPORE
author_facet	CANCER SCIENCE INSTITUTE OF SINGAPORE Lim, JSJ Wong, ALA Ow, SGW Ngoi, NYL Chan, GHJ Ang, YLE Chong, WQ Lim, SE Lim, YW Lee, M Choo, JRE Tan, HL Yong, WP Soo, RA Tan, DSP Chee, CE Sundar, R Yadav, K Jain, S Wang, L Tai, BC Goh, BC Lee, SC
format	Article
author	Lim, JSJ Wong, ALA Ow, SGW Ngoi, NYL Chan, GHJ Ang, YLE Chong, WQ Lim, SE Lim, YW Lee, M Choo, JRE Tan, HL Yong, WP Soo, RA Tan, DSP Chee, CE Sundar, R Yadav, K Jain, S Wang, L Tai, BC Goh, BC Lee, SC
author_sort	Lim, JSJ
title	Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer
title_short	Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer
title_full	Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer
title_fullStr	Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer
title_full_unstemmed	Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer
title_sort	phase ib/ii dose expansion study of lenvatinib combined with letrozole in postmenopausal women with hormone receptor–positive breast cancer
publisher	American Association for Cancer Research (AACR)
publishDate	2023
url	https://scholarbank.nus.edu.sg/handle/10635/236980
_version_	1800915772167421952

Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer

Similar Items